EPA rules Glyphosate a Non-Carcinogen

Feb 7, 2020  | 2 min  | Ep4525

Since its introduction in 1974, glyphosate, marketed under the name Roundup, has had a significant influence on global agriculture. Many GMO crop varieties were developed specifically to allow the direct application of the weed killer.

Peter Tubbs has more as the EPA stood up for Roundup.

The Environmental Protection Agency has issued an interim decision on one of the world’s most productive and controversial weed killers.
The regulatory review by the EPA reaffirms the agency’s stance that glyphosate does not cause cancer. 
Glyphosate, the key ingredient in Bayer AG’s Roundup, has been the target of litigation charging that exposure to the chemical leads to cancer in its users. Multiple juries have awarded millions to cancer patients who believe their illnesses were caused by the herbicide.
The EPA judgement follows similar findings by regulatory bodies in the European Union, Australia and Canada. In 2015, the International Agency on the Research for Cancer declared glyphosate a probable carcinogen. The EPA claims it considered a larger dataset than the IARC to arrive at its non-carcinogen conclusion. 
The EPA also found no indication that children are more sensitive than adults to glyphosate, or that the chemical is an endocrine disruptor. The EPA also considers trace amounts of glyphosate in the food supply to be safe.
Bayer AG, which bought Monsanto in 2018, has maintained that glyphosate and Roundup are safe for both users and the environment at large. The agricultural chemical company is appealing the court verdicts against them. Reuters is reporting the agricultural chemical giant also has begun settlement talks. 
The EPA is expected to render its final decision by the end of the year.

For Market to Market, I’m Peter Tubbs. @petertubbs

Grinnell Mutual Insurance